MDT - Silk Road Medical Files For IPO
Quick Take
Silk Road Medical (SILK) intends to raise $86.25 million in an IPO of its common stock, according to an S-1 registration statement.
The firm is commercializing a transcarotid artery stenting device in the United States.
SILK is growing well and has significant growth opportunities ahead, within the U.S., the EU, and potentially in the Asia Pacific region.
When we learn more details from management, I’ll provide an update.
Company & Technology
Sunnyvale, California-based Silk Road Medical was founded in 2007 to develop an effective treatment to reduce the probability of